InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Sagimet Biosciences Inc.

SGMT Clue Score32
United States Fiscal year ends December CIK 0001400118 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

24
Insider
Date
Role
Action
Shares
Price
Amount
George Kemble
14 Aug 2026
Director
Sold after exercise
350,987
$10.23
$3.59M
George Kemble
11 Aug 2026
Director
Sold after exercise
20,206
$9.95
$201.15K
George Kemble
20 Jul 2026
Director
Sold on a plan
18,844
$7.46
$140.53K
Elizabeth Rozek
20 Jul 2026
Chief Legal & Admin. Officer
Sell
10,545
$7.76
$81.83K
David Happel
20 Jul 2026
President & CEO
Sell
64,051
$7.76
$497.07K
Elizabeth Rozek
10 Feb 2026
Chief Legal & Admin. Officer
Sell
2,622
$5.36
$14.05K
Eduardo Bruno Martins
10 Feb 2026
Chief Medical Officer
Sell
3,640
$5.36
$19.51K
Thierry Chauche
10 Feb 2026
Chief Financial Officer
Sell
1,312
$5.36
$7.03K
David Happel
10 Feb 2026
President & CEO
Sell
12,101
$5.36
$64.86K
George Kemble
20 Nov 2025
Executive Chairman
Sold on a plan
37,688
$7.69
$289.98K
Elizabeth Rozek
21 Jul 2025
General Counsel and CCO
Sell
10,780
$9.13
$98.47K
Eduardo Bruno Martins
21 Jul 2025
Chief Medical Officer
Sell
8,277
$9.13
$75.61K
David Happel
21 Jul 2025
President & CEO
Sell
65,478
$9.13
$598.12K
George Kemble
23 Jul 2024
Executive Chairman
Sold on a plan
23,625
$3.17
$74.83K
George Kemble
19 Jul 2024
Executive Chairman
Sell
14,062
$3.10
$43.60K
Elizabeth Rozek
19 Jul 2024
General Counsel and CCO
Sell
10,914
$3.10
$33.83K
Eduardo Bruno Martins
19 Jul 2024
Chief Medical Officer
Sell
8,357
$3.10
$25.91K
David Happel
26 Mar 2024
President & CEO
Buy
12,100
$5.27
$63.73K
David Happel
7 Dec 2023
President & CEO
Buy
1,600
$4.10
$6.56K
David Happel
16 Nov 2023
President & CEO
Buy
590
$2.35
$1.39K
George Kemble
7 Sep 2023
Executive Chairman
Exercised, kept
5,630
$0.79
$4.45K
Beth C Seidenberg
18 Jul 2023
Director
Buy indirect
46,875
$16.00
$750.00K
New Enterprise Associates 13 LP
18 Jul 2023
10% owner
Buy
30,000
$16.00
$480.00K
New Enterprise Associates 13 LP
18 Jul 2023
10% owner
Sold after exercise
662
$16.00
$10.59K

What was left out

Form 4 filings counted 80
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 3
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 17,749,393
History held since 20 Jul 2023